Firms & Funds

IPOs/Recent Issues 0301 –

-
PEET’S COFFEE & TEA
Emeryville, Calif.

Went public 01/25/01

Filing Range: 3.3 million shares @ $8 to $12
Share Outstanding: 8.0 million shares
Underwriters: W.R. Hambrecht + Co./Pacific Growth Equities Inc.
Company Counsel: Cooley Godward LLP
Manager Counsel: Morrison & Foerster
Auditor: Deloitte & Touche LLP
The Company:
Operates about 60 specialty coffee stores in four states offering coffee, teas, mugs, and equipment. In addition the company also sells products through mail order, its Web site and retail grocery stores.
Venture Backers:
Chase H&Q

Financing Rounds:
Round # Round Date Number of Stage Investors Round Amt. ($ thousands)
1 10/01/1996 1 Early Stage 1200.0
2 03/13/1998 1 Early Stage 270.0
Financials:
(Data in $ millions) Y/E
12/31/99
Total Revenues: $67.8
Net Income: (0.9)

ALIGN TECHNOLOGY
Sunnyvale, Calif.

Went public 01/26/01

Filing Range: 10.0 million shares @ $14 to $16
Shares Outstanding: 45.6 million shares
Underwriters: Deutsche Banc Alex. Brown/Bear, Stearns & Co./ J.P. Morgan & Co./Robertson Stephens Inc.
Company Counsel: Brobeck Phleger & Harrison LLP
Manager Counsel: Wilson Sonsini Goodrich & Rosati
Auditor: Pricewaterhouse Coopers LLP
The Company:
Develops orthodonture devices. The company focuses on the application of new technology to medical device design. The company uses recent technological advances in three-dimensional scanning, computer graphics and rapid prototyping systems to drive the design and manufacture of its products.
Venture Backers:
The Carlyle Group

Oak Hill Capital Management Inc.

Kleiner, Perkins, Caufield & Byers

ABS Ventures

Domain Associates LLC

Comdisco Ventures

Vector Fund Management LP

BancBoston/Robertson Stephens Inc.

QuestMark Partners LP

Synergy Partners

Financing Rounds:
Round # Round Date Number of Stage Investors Round Amt. ($ thousands)
1 07/01/1997 1 Early Stage 2000.0
2 07/13/1998 5 Early Stage 9330.0
3 09/24/1999 8 Expansion 26000.0
4 06/21/2000 5 Later Stage 86000.0
5 09/15/2000 1 Expansion 400.0
Financials:
(Data in $ millions) Y/E
12/31/99
Total Revenues: $0.4
Net Income: (1.3)

EXACT SCIENCES CORP.
Maynard, Mass.

Went public 01/31/01

Filing Range: 4.0 million shares @ $14 to $16
Shares Outstanding: 18.6 million shares
Underwriters: Merrill Lynch & Co. Inc./CIBC World Markets/ Thomas Weisel Partners LLC
Company Counsel: Testa Hurwitz & Thibeault
Manager Counsel: Shearman & Sterling
Auditor: Arthur Andersen LLP
The Company:
Develops stool-based early detection test for colorectal cancer. The company has developed proprietary technologies in applied genomics that aids in the early detection of colorectal cancer and several other types of common cancers.
Venture Backers:
Highland Capital Partners

OneLiberty Ventures

Greylock Management Corp.

Boston University Community Technology Fund

CB Health Ventures LLC

Robertson Stephens Inc.

HLM Management Co.

PaineWebber Group Inc./McKinley Allsop

Vulcan Ventures Inc.

Galleon Management Inc.

Mayo Medical Ventures

BancBoston

Gilde Venture Fund

Financing Rounds:
Round # Round Date Number of Stage Investors Round Amt. ($ thousands)
1 02/01/1995 3 Early Stage 200.0
2 02/01/1996 1 Early Stage 99.0
3 04/01/1996 3 Early Stage 800.1
4 02/01/1997 5 Early Stage 3935.0
5 03/17/1998 10 Expansion 10575.2
6 04/03/2000 19 Later Stage 31895.0
Financials:
(Data in $ millions) Y/E
12/31/99
Total Revenues: $0.0
Net Income (5.0)